Sinotherapeutics, Inc. engages in the research and development, production and sales of generic drugs and Contract Research Organization (CRO) services. It also provides technology development, technology transfer, technical consultation, technical services, operating the import and export business of the company's self-produced products and related technologies, chemical raw materials, laboratory equipment, instrument wholesale, import and export, commission agency, and provide related supporting services. The company was founded on August 13, 2012 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company